½Ã °£ Á¦ ¸ñ °­ »ç
Session I - Hot topics in this year
09:00~09:30 Cerebral perfusion, autoregulation, and metabolism in patients with diabetes ÇѸ²ÀÇ´ë À¯°æÈ£
09:30~10:00 Hepatic insulin resistance ±¹¸³º¸°Ç¿¬±¸¿ø ¼ÛÁöÇö
10:00~10:30 CV risk management; Subclinical CAD in patients with T2DM °¡Å縯ÀÇ´ë ±ÇÇõ»ó
10:30~10:50 Coffee Break
Session II - Incretin
10:50~11:20 GLP-1, the Mechanism of Action in beta cells °è¸íÀÇ´ë ¼Û´ë±Ô
11:20~11:50 GLP-1 based treatment in Diabetes °¡Å縯ÀÇ´ë Á¶ÀçÇü
11:50~12:20 GLP-1 treatment, beyond Diabetes °Ç¾çÀÇ´ë ±èº´ÁØ
12:20~13:20 Lunch
Session III - Dilemmas in the insulin treatment of diabetic patients
13:20~13:50 Brittle Diabetes in type 1 diabetes mellitus ¼º±Õ°üÀÇ´ë ±èÀçÇö
13:50~14:20 Insulin therapy in highly insulin resistant type 2 diabetes mellitus °æÈñÀÇ´ë ¾È±ÔÁ¤
14:20~14:50 New insulin regimens; long acting, inhaled & oral form etc. ÀÎÁ¦ÀÇ´ë °í°æ¼ö
14:50~15:10 Coffee Break
Session IV - Diabetic retinopathy
15:10~15:40 Interpretation of fundus photograpy ¼øÃµÇâÀÇ´ë À̼ºÁø
15:40~16:10 Update on the treatment of diabetic retinopathy ¿¬¼¼ÀÇ´ë ±è¼º¼ö